Title

Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours
Effectiveness of Two Non-surgical Periodontal Treatment Protocols: Randomized Controlled Clinical Trial
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    azithromycin chlorhexidine ...
  • Study Participants

    130
Periodontitis is a form of gum disease that affects many people in the world. Its traditional protocol of treatment includes oral hygiene instruction and dental scaling to remove debris, dental plaque and tartar in 4 weekly sections. There is an additional time-reduced option also usually cheaper. In this last one, all above described procedures are performed within 24 hours. However, up to now comparative effectiveness between these both types of treatment is not well understood. For, example it is not clear if patients treated in the shorter-time experienced more pain. Therefore, the present study used several parameters to clarify whether beneficial differences between these therapeutic protocols exist or not. In addition, aspects that could help clinicians' and patient's decisions such as experience of pain and anxiety related to dental treatment were also investigated. After receiving verbal and written explanations and signed the informed consent form 150 individuals (n=15/group) having the most common type of periodontitis in adults were randomly allocated to be treated in 4 weekly sections or within 24 hours. Oral hygiene instructions and dental debridement were performed alone or in conjunction with antimicrobial agents: a mouth rinse containing chlorhexidine or systemic azithromycin antibiotic tablets. The parameters measured at baseline, 3, 6 and 9 months after treatment were: indicators of inflammation, amount of oral debris and malodor; quantification of bacteria in plaque samples collected with paper points from teeth and tongue; amount of produced saliva and self-reported questionnaires to collect information about oral condition, daily activities, pain and anxiety related to dental treatment.
Study Started
Apr 30
2012
Primary Completion
Mar 31
2014
Study Completion
Apr 30
2014
Last Update
Aug 13
2014
Estimate

Procedure FMS full-mouth scaling

Participants received oral hygiene instructions and full-mouth scaling within 24 hours. Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Procedure QS quadrant scaling

Participants received oral hygiene instructions and quadrant scaling in 4 weekly sections. Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug FMS chlorhexidine rinse

Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 60-day use of 0.12% chlorhexidine mouth rinse (15mL/30 seconds/ 2 times a day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug FMS placebo rinse

Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 60-day use of placebo mouth rinse (15mL/30 seconds/ 2 times a day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug FMS azithromycin tablets

Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 3-day use of azithromycin tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug FMS placebo tablets

Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 3-day use of placebo tablets (1 tablet/day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug QS azithromycin tablets

Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 3-day use of azithromycin tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug QS placebo tablets

Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 3-day use of placebo tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug QS chlorhexidine rinse

Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 60-day use of 0.12% chlorhexidine mouth rinse (15mL/30 seconds/2 times a day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Drug QS placebo rinse

Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 60-day use of 0.12% placebo mouth rinse (15mL/30 seconds/2 times a day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.

Full-mouth scaling (FMS) Experimental

FMS chlorhexidine rinse Experimental

FMS azithromycin tablets Experimental

FMS placebo rinse Placebo Comparator

Quadrant scaling (QS) Experimental

QS chlorhexidine rinse Experimental

QS azithromycin tablets Experimental

QS placebo tablets Placebo Comparator

FMS placebo tablets Placebo Comparator

QS placebo rinse Placebo Comparator

Criteria

Inclusion Criteria:

mild to moderate chronic periodontitis;
at least 20 natural teeth;
good general health

Exclusion Criteria:

systemic diseases or other conditions that could influence the periodontal status;
events of high blood pressure or diagnosed hypertension;
alcohol abuse;
orthodontic devices;
extended prosthetic fixed devices, removable partial dentures or overhanging restorations;
pregnancy or breast-feeding;
history of sensitivity or suspected allergies following the use of oral hygiene products and/or the test antibiotic;
the need for antibiotic prophylaxis;
antibiotics and/or anti-inflammatory drug use in the three months prior to the beginning of the study;
regular use of chemotherapeutic antiplaque/antigingivitis products;
any furcation lesions;
periodontal treatment performed within six months prior to study initiation;
unwillingness to return for follow-up.
No Results Posted